サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1311109

侵襲性真菌感染症の世界市場規模調査＆予測：疾患タイプ別、薬剤タイプ別、地域別分析、2023-2030年

Global Invasive Fungal Infection Market Size Study & Forecast, by Disease Type, By Drug Type, and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
侵襲性真菌感染症の世界市場規模調査＆予測：疾患タイプ別、薬剤タイプ別、地域別分析、2023-2030年
出版日: 2023年07月11日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

侵襲性真菌感染症は、真菌が血流に入り、体の他の部分に広がることで起こる重篤な感染症です。

このような感染症は、特にがん、HIV/AIDS、臓器移植など免疫力が低下している人では、生命を脅かすことがあります。侵襲性真菌感染症を引き起こす真菌には多くの種類があります。侵襲性真菌感染症市場は、様々な真菌感染症に関する認識を高めるための公的機関や民間団体によるイニシアチブの高まり、人々の可処分所得の増加、侵襲性真菌感染症の発生率の増加などの要因により拡大しています。

加えて、HIVに罹患している人口の増加が、世界中で市場成長の触媒として作用しています。HIV.govによると、2021年には全世界で約3,840万人がHIVに罹患しており、そのうち170万人が小児（15歳未満）、3,670万人が成人であると推定されています。また、2021年には世界中で約150万人がHIVに感染しています。したがって、これらの前述の要因は、推定期間中の侵襲性真菌感染症市場の成長を推進しています。さらに、パイプライン医薬品や施設の発見や進歩、新規抗真菌薬に対する需要の高まりは、予測期間中に様々な有利な機会をもたらします。しかし、熟練した専門家の不足や認知度の低さが、2023-2030年の予測期間を通じて市場成長の課題となっています。

侵襲性真菌感染症の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、入院期間の長期化、免疫抑制療法の使用増加、他の部位での真菌のコロニー形成または感染により、2022年の市場を独占しました。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されます。HIVに罹患している人口の増加、可処分所得の増加、様々な真菌感染症に対する意識の高まりが、この地域全体の市場需要を大きく押し上げています。

本調査の目的は、近年における様々なセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 侵襲性真菌感染症市場：地域別、2020年～2030年
    • 侵襲性真菌感染症市場：疾患タイプ別、2020-2030年
    • 侵襲性真菌感染症市場：薬剤タイプ別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査想定

第2章 侵襲性真菌感染症の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 侵襲性真菌感染症の世界市場力学

  • 侵襲性真菌感染症市場のインパクト分析（2020-2030年）
    • 市場促進要因
      • HIV感染者の増加
      • 様々な真菌感染症に対する認識を高めるための公的機関および民間機関によるイニシアティブの高まり
    • 市場の課題
      • 熟練した専門家の不足
      • 認識不足
    • 市場機会
      • パイプライン医薬品や施設の発見と進歩
      • 新規抗真菌薬に対する需要の高まり

第4章 侵襲性真菌感染症の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 侵襲性真菌感染症の世界市場：疾患タイプ別

  • 市場スナップショット
  • 侵襲性真菌感染症の世界市場：疾患タイプ別、実績-潜在能力分析
  • 侵襲性真菌感染症の世界市場：疾患タイプ別、推定・予測、2020-2030年
  • 侵襲性真菌感染症市場、サブセグメント分析
    • カンジダ真菌症および侵襲性カンジダ症
    • 腹腔内カンジダ症
    • クリプトコッカス髄膜炎
    • 食道カンジダ症
    • 急性肺ヒストプラスマ症
    • その他

第6章 侵襲性真菌感染症の世界市場：薬剤タイプ別

  • 市場スナップショット
  • 侵襲性真菌感染症の世界市場：薬剤タイプ別、実績-潜在能力分析
  • 侵襲性真菌感染症の世界市場：薬剤タイプ別推定・予測2020-2030年
  • 侵襲性真菌感染症市場、サブセグメント分析
    • ポリエン
    • アムホテリシンBデオキシコール酸塩
    • 脂質製剤アムホテリシンB
    • その他

第7章 侵襲性真菌感染症の世界市場、地域分析

  • 主要国
  • 主な新興国
  • 侵襲性真菌感染症市場、地域別市場スナップショット
  • 北米
    • 米国
      • 疾患タイプの推定・予測、2020～2030年
      • 薬剤タイプの推定・予測、2020～2030年
    • カナダ
  • 欧州侵襲性真菌感染症市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋侵襲性真菌感染症市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの侵襲性真菌感染症市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Cidara Therapeutics, Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Basilea Pharmaceutica AG Allschwil
    • Pfizer
    • GlaxoSmith Kline
    • Bayer AG
    • Abbott
    • Merck & Co, Inc.
    • Astellas Pharma Inc.
    • Scynexis Inc.
    • BioMarin Pharmaceutical Inc.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提
図表

LIST OF TABLES

  • TABLE 1. Global Invasive Fungal Infection Market, report scope
  • TABLE 2. Global Invasive Fungal Infection Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Invasive Fungal Infection Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
  • TABLE 4. Global Invasive Fungal Infection Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
  • TABLE 5. Global Invasive Fungal Infection Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Invasive Fungal Infection Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Invasive Fungal Infection Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Invasive Fungal Infection Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Invasive Fungal Infection Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Invasive Fungal Infection Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Invasive Fungal Infection Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Invasive Fungal Infection Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Invasive Fungal Infection Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Invasive Fungal Infection Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Invasive Fungal Infection Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Invasive Fungal Infection Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Invasive Fungal Infection Market
  • TABLE 70. List of primary sources, used in the study of global Invasive Fungal Infection Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Invasive Fungal Infection Market, research methodology
  • FIG 2. Global Invasive Fungal Infection Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Invasive Fungal Infection Market, key trends 2022
  • FIG 5. Global Invasive Fungal Infection Market, growth prospects 2023-2030
  • FIG 6. Global Invasive Fungal Infection Market, porters 5 force model
  • FIG 7. Global Invasive Fungal Infection Market, pest analysis
  • FIG 8. Global Invasive Fungal Infection Market, value chain analysis
  • FIG 9. Global Invasive Fungal Infection Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Invasive Fungal Infection Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Invasive Fungal Infection Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Invasive Fungal Infection Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Invasive Fungal Infection Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Invasive Fungal Infection Market, regional snapshot 2020 & 2030
  • FIG 15. North America Invasive Fungal Infection Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Invasive Fungal Infection Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Invasive Fungal Infection Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Invasive Fungal Infection Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Invasive Fungal Infection Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Invasive Fungal Infection Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. An invasive fungal infection is a serious infection that occurs when fungi enter the bloodstream and spread to other parts of the body. These infections can be life-threatening, especially in people who are immunocompromised, such as those with cancer, HIV/AIDS, or organ transplants. There are many different types of fungi that cause invasive fungal infections. The Invasive Fungal Infection Market is expanding because of factors such as the growing initiatives by public and private organizations to raise awareness about a variety of fungal infections, rising disposable income of people, and increasing incidence of invasive fungal infections.

In addition, the rise in the population suffering from HIV is acting as a catalyzing factor for market growth across the globe. ``According to HIV.gov, in 2021, it was estimated that nearly 38.4 million people worldwide are suffering from HIV, of which 1.7 million were children (<15 years old) and 36.7 million were adults. Also, in 2021, approximately 1.5 million individuals around the globe acquired HIV. Thus, these aforementioned factors are propelling the growth of the Invasive Fungal Infection Market during the estimated period. Moreover, the discoveries and advancements of pipeline drugs and facilities, as well as the growing demand for novel antifungal drugs present various lucrative opportunities over the forecasting years. However, the unavailability of skilled professionals and the lack of awareness are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Invasive Fungal Infection Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the prolonged hospital stays, rising use of immunosuppressive therapies, and fungal colonization or infection at other sites. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rise in the population suffering from HIV, rising disposable income, and raise awareness about a variety of fungal infections are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Cidara Therapeutics, Inc.
  • Basilea Pharmaceutica AG Allschwil
  • Pfizer
  • GlaxoSmith Kline
  • Bayer AG
  • Abbott
  • Merck & Co, Inc.
  • Astellas Pharma Inc.
  • Scynexis Inc.
  • BioMarin Pharmaceutical Inc.

Recent Developments in the Market:

  • In March 2023, the U.S. Food and Drug Administration (FDA) has granted approval for rezafungin for injection, (REZZAYOTM), as a treatment for patients with candidemia and invasive candidiasis. The newly approved drug is the first to be licenced in more than ten years for the invasive fungal disease. It is a new antifungal treatment administered intravenously once a week.

Global Invasive Fungal Infection Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Disease Type, Drug Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

  • Candidaemi Caa and Invasive Candiasis
  • Intra-abdominal Candiasis
  • Cryptococcal Meningitis
  • Esophageal Candidiasis
  • Histoplasmosis Acute Pulmonary
  • Others

By Drug Type:

  • Polyenes
  • Amphotericin B Deoxycholate
  • Lipid Formulation Amphotericin B
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Invasive Fungal Infection Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Invasive Fungal Infection Market, by Disease Type, 2020-2030 (USD Billion)
    • 1.2.3. Invasive Fungal Infection Market, by Drug Type, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Invasive Fungal Infection Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Invasive Fungal Infection Market Dynamics

  • 3.1. Invasive Fungal Infection Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in the population suffering from HIV
      • 3.1.1.2. Growing initiatives by public and private organizations to raise awareness about a variety of fungal infections
    • 3.1.2. Market Challenges
      • 3.1.2.1. Unavailability of skilled professionals
      • 3.1.2.2. Lack of awareness
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Discoveries and advancements of pipeline drugs and facilities
      • 3.1.3.2. Growing demand for novel antifungal drugs

Chapter 4. Global Invasive Fungal Infection Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Invasive Fungal Infection Market, by Disease Type

  • 5.1. Market Snapshot
  • 5.2. Global Invasive Fungal Infection Market by Disease Type, Performance - Potential Analysis
  • 5.3. Global Invasive Fungal Infection Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
  • 5.4. Invasive Fungal Infection Market, Sub Segment Analysis
    • 5.4.1. Candidaemi Caa and Invasive Candiasis
    • 5.4.2. Intra-abdominal Candiasis
    • 5.4.3. Cryptococcal Meningitis
    • 5.4.4. Esophageal Candidiasis
    • 5.4.5. Histoplasmosis Acute Pulmonary
    • 5.4.6. Others

Chapter 6. Global Invasive Fungal Infection Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Invasive Fungal Infection Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Invasive Fungal Infection Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
  • 6.4. Invasive Fungal Infection Market, Sub Segment Analysis
    • 6.4.1. Polyenes
    • 6.4.2. Amphotericin B Deoxycholate
    • 6.4.3. Lipid Formulation Amphotericin B
    • 6.4.4. Others

Chapter 7. Global Invasive Fungal Infection Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Invasive Fungal Infection Market, Regional Market Snapshot
  • 7.4. North America Invasive Fungal Infection Market
    • 7.4.1. U.S. Invasive Fungal Infection Market
      • 7.4.1.1. Disease Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Drug Type breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Invasive Fungal Infection Market
  • 7.5. Europe Invasive Fungal Infection Market Snapshot
    • 7.5.1. U.K. Invasive Fungal Infection Market
    • 7.5.2. Germany Invasive Fungal Infection Market
    • 7.5.3. France Invasive Fungal Infection Market
    • 7.5.4. Spain Invasive Fungal Infection Market
    • 7.5.5. Italy Invasive Fungal Infection Market
    • 7.5.6. Rest of Europe Invasive Fungal Infection Market
  • 7.6. Asia-Pacific Invasive Fungal Infection Market Snapshot
    • 7.6.1. China Invasive Fungal Infection Market
    • 7.6.2. India Invasive Fungal Infection Market
    • 7.6.3. Japan Invasive Fungal Infection Market
    • 7.6.4. Australia Invasive Fungal Infection Market
    • 7.6.5. South Korea Invasive Fungal Infection Market
    • 7.6.6. Rest of Asia Pacific Invasive Fungal Infection Market
  • 7.7. Latin America Invasive Fungal Infection Market Snapshot
    • 7.7.1. Brazil Invasive Fungal Infection Market
    • 7.7.2. Mexico Invasive Fungal Infection Market
  • 7.8. Middle East & Africa Invasive Fungal Infection Market
    • 7.8.1. Saudi Arabia Invasive Fungal Infection Market
    • 7.8.2. South Africa Invasive Fungal Infection Market
    • 7.8.3. Rest of Middle East & Africa Invasive Fungal Infection Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Cidara Therapeutics, Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Basilea Pharmaceutica AG Allschwil
    • 8.3.3. Pfizer
    • 8.3.4. GlaxoSmith Kline
    • 8.3.5. Bayer AG
    • 8.3.6. Abbott
    • 8.3.7. Merck & Co, Inc.
    • 8.3.8. Astellas Pharma Inc.
    • 8.3.9. Scynexis Inc.
    • 8.3.10. BioMarin Pharmaceutical Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption